3 Reasons CRISPR Therapeutics Stock Can Reach Record Highs Again
Shares of CRISPR Therapeutics (NASDAQ: CRSP) have gained 52% in 2019, but the stock is still 40% below the record high price it reached in 2018. If you've been holding onto shares of the gene-editing pioneer since their heyday last May, now is not the time to let go.
While reporting third-quarter earnings, management highlighted a few catalysts that could send the biotech stock through the roof. Here are three big ones to look out for.
Image source: Getty Images.
Source Fool.com
